Breast Cancer Canada — Call for Proposals: Lobular Carcinoma
This program is currently closed. The details below reflect the previous call and are for general information purposes only.
Breast Cancer Canada is now accepting applications for the 2026 Research Grant competition, awarding a total of $250,000 CAD to accelerate precision oncology in Lobular Carcinoma breast cancer. This national grant program is designed to fuel innovation in precision diagnostics and targeted treatment driven by Canadian research teams who are shaping the future of breast cancer care.
Funding Value and Duration
| Research Focus | Budget Category 1 | Budget Category 2 |
|---|---|---|
| Targeted Diagnostics (Screening, Detection or Follow-up) | $75,000 (3 x $25,000 annually) | $50,000 (2 x $25,000 annually) |
| Targeted Treatment (Surgery, Medicine or Radiation) | $75,000 (3 x $25,000 annually) | $50,000 (2 x $25,000 annually) |
Sponsor’s Website
Internal Contacts
Deadlines
| Deadline | Date |
|---|---|
| Faculty Deadline | Consult your Faculty Research Facilitator |
| OVPRII Approval Form Deadline | December 5, 2025 |
| Letter of Intent | December 12, 2025 by 5 p.m. (PT) |
| Submission Deadline | February 13, 2026 by 5 p.m. (PT) |
Submitting Your Application
- Log in to cuResearch and submit an internal Carleton Approval Form. Review the cuResearch user’s manual.
- Submit an external application to Breast Cancer Canada by following their submission guidelines.